Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
US 9,345,680 Term endedTerm ended no later than Jul 24, 2026 · From the USPTO record
20-year base term ended Jul 24, 2026
Jul 24, 2006
Jul 24, 2026
May 24, 2016
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 24, 2006, when the earliest non-provisional application in its chain was filed (this one was filed Mar 27, 2015); a parent in its chain could not be resolved (the next row) | Jul 24, 2026 | From the USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | From the USPTO record |
| Patent term adjustment | No term adjustment record on a grant after 2005, so none is added | no change | From the USPTO record |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | From the USPTO record |
| Patent term extension | None on file | no change | From the USPTO record |
| Fee events | 2 of 2 maintenance fees paid | term ended | From the USPTO record |
| Computed term end | The steps above, in order | no later than Jul 24, 2026 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.